351
|
Landin-Romero R, Tan R, Hodges JR, Kumfor F. An update on semantic dementia: genetics, imaging, and pathology. ALZHEIMERS RESEARCH & THERAPY 2016; 8:52. [PMID: 27915998 PMCID: PMC5137205 DOI: 10.1186/s13195-016-0219-5] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Progressive and relatively circumscribed loss of semantic knowledge, referred to as semantic dementia (SD) which falls under the broader umbrella of frontotemporal dementia, was officially identified as a clinical syndrome less than 50 years ago. Here, we review recent neuroimaging, pathological, and genetic research in SD. From a neuroimaging perspective, SD is characterised by hallmark asymmetrical atrophy of the anterior temporal pole and anterior fusiform gyrus, which is usually left lateralised. Functional magnetic resonance imaging (fMRI) studies have revealed widespread changes in connectivity, implicating the anterior temporal regions in semantic deficits in SD. Task-related fMRI have also demonstrated the relative preservation of frontal and parietal regions alongside preserved memory performance. In addition, recent longitudinal studies have demonstrated that, with disease progression, atrophy encroaches into the contralateral temporal pole and medial prefrontal cortices, which reflects emerging changes in behaviour and social cognition. Notably, unlike other frontotemporal dementia subtypes, recent research has demonstrated strong clinicopathological concordance in SD, with TDP43 type C as the most common pathological subtype. Moreover, an underlying genetic cause appears to be relatively rare in SD, with the majority of cases having a sporadic form of the disease. The relatively clear diagnosis, clinical course, and pathological homogeneity of SD make this syndrome a promising target for novel disease-modifying interventions. The development of neuroimaging markers of disease progression at the individual level is an important area of research for future studies to address, in order to assist with this endeavour.
Collapse
Affiliation(s)
- Ramon Landin-Romero
- Neuroscience Research Australia, PO Box 1165, Randwick, Sydney, NSW, 2031, Australia.,School of Medical Sciences, the University of New South Wales, Sydney, Australia.,ARC Centre of Excellence in Cognition and its Disorders, Sydney, Australia
| | - Rachel Tan
- Neuroscience Research Australia, PO Box 1165, Randwick, Sydney, NSW, 2031, Australia.,School of Medical Sciences, the University of New South Wales, Sydney, Australia
| | - John R Hodges
- Neuroscience Research Australia, PO Box 1165, Randwick, Sydney, NSW, 2031, Australia.,School of Medical Sciences, the University of New South Wales, Sydney, Australia.,ARC Centre of Excellence in Cognition and its Disorders, Sydney, Australia
| | - Fiona Kumfor
- Neuroscience Research Australia, PO Box 1165, Randwick, Sydney, NSW, 2031, Australia. .,School of Medical Sciences, the University of New South Wales, Sydney, Australia. .,ARC Centre of Excellence in Cognition and its Disorders, Sydney, Australia.
| |
Collapse
|
352
|
Ljubenkov PA, Miller BL. A Clinical Guide to Frontotemporal Dementias. FOCUS (AMERICAN PSYCHIATRIC PUBLISHING) 2016; 14:448-464. [PMID: 31975825 PMCID: PMC6519586 DOI: 10.1176/appi.focus.20160018] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The term frontotemporal dementia (FTD) describes a diverse group of clinical syndromes, including behavioral-variant FTD (bvFTD), nonfluent/agrammatic-variant primary progressive aphasia (nfvPPA), semantic-variant primary progressive aphasia (svPPA), FTD motor neuron disease (FTD-MND), progressive supranuclear palsy syndrome (PSP-S), and corticobasal syndrome (CBS). Although each of these syndromes may be distinguished by their respective disturbances in behavior, language, or motor function and characteristic imaging findings, they may present a diagnostic dilemma when encountered clinically. In this article, we review the clinical features, diagnostic criteria, pathology, genetics, and therapeutic interventions for FTD spectrum disorders.
Collapse
Affiliation(s)
- Peter A Ljubenkov
- Dr. Ljubenkov is a clinical fellow and Dr. Miller is professor of neurology in the Department of Neurology, University of California, San Francisco, School of Medicine (e-mail: )
| | - Bruce L Miller
- Dr. Ljubenkov is a clinical fellow and Dr. Miller is professor of neurology in the Department of Neurology, University of California, San Francisco, School of Medicine (e-mail: )
| |
Collapse
|